OpenAlex
PricingAboutJobs
Log inGet started
Work

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)

HTML

Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2006.04.006
Authors: Gunter von Minckwitz, Erika Graf, Matthias Geberth, Wolfgang Eiermann, Walter Jonat, Bettina Conrad, Klaus Brunnert, Bernd Gerber, Sabine Vescia, Jörg Wollert, Manfred Kaufmann
Institutions: German Breast Group, University Hospital Frankfurt, University Medical Center Freiburg, Frauenklinik Heidelberg, Rotkreuzklinikum München, University Hospital Schleswig-Holstein, Klinikum Osnabrück, TUM Klinikum, Klinikum Hanau, AstraZeneca (Germany)
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: goserelin, CMF chemotherapy, adjuvant therapy, node-negative breast cancer, hormone receptor-positive breast cancer, premenopausal women, GnRH analogues, contralateral breast cancer, locoregional recurrence, distant failure, breast cancer mortality
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Deutsche Krebshilfe
OpenAlex ID: W2010540445
FWCI: 2.14
Cites: 26
Cited by: 48
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security